TipRanks
Medpace Holdings (MEDP)
NASDAQ:MEDP
US Market
MEDP
Medpace Holdings
RESEARCH TOOLSreports
Want to see MEDP full AI Analyst Report?

Medpace Holdings (MEDP) Stock Forecast & Price Target

686 Followers
See the Price Targets and Ratings of:

MEDP Analyst Ratings

Hold
12Ratings
Hold
2 Buy
10 Hold
0 Sell
Based on 12 analysts giving stock ratings to
Medpace
Holdings
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

MEDP Stock 12 Month Forecast

Average Price Target

$612.10
▼(-0.32% Downside)
Based on 12 Wall Street analysts offering 12 month price targets for Medpace Holdings in the last 3 months. The average price target is $612.10 with a high forecast of $700.00 and a low forecast of $492.00. The average price target represents a -0.32% change from the last price of $614.06.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"416":"$416","701":"$701","487.25":"$487.3","558.5":"$558.5","629.75":"$629.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":700,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$700.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":612.1,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$612.10</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":492,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$492.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[416,487.25,558.5,629.75,701],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,598.08,605.9200000000001,613.76,621.6,629.44,637.28,645.12,652.96,660.8000000000001,668.64,676.48,684.32,692.16,{"y":700,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,598.08,599.1584615384616,600.2369230769231,601.3153846153847,602.3938461538462,603.4723076923077,604.5507692307692,605.6292307692308,606.7076923076924,607.7861538461539,608.8646153846154,609.943076923077,611.0215384615385,{"y":612.1,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,598.08,589.9200000000001,581.76,573.6,565.44,557.28,549.12,540.96,532.8,524.64,516.48,508.32,500.15999999999997,{"y":492,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":543.9,"date":1759276800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":584.91,"date":1761955200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":587.98,"date":1764547200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":561.65,"date":1767225600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":588.17,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":457.47,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":489.48,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":417.54,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":451.47,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":543.57,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":577.11,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":583.21,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":598.08,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$700.00Average Price Target$612.10Lowest Price Target$492.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Barclays Analyst forecast on MEDP
Luke Sergott
Barclays
Barclays
$450→$625
Hold
1.78%
Upside
Reiterated
10/07/26
Medpace Holdings (MEDP) Gets a Hold from Barclays
Mizuho Securities Analyst forecast on MEDP
Ann Hynes
Mizuho Securities
Mizuho Securities
$665→$700
Buy
14.00%
Upside
Reiterated
10/07/26
Medpace price target raised to $700 from $665 at MizuhoMedpace price target raised to $700 from $665 at Mizuho
RBC Capital Analyst forecast on MEDP
Ryan Halsted
RBC Capital
RBC Capital
$692
Buy
12.69%
Upside
Reiterated
10/06/26
Medpace Holdings (MEDP) Receives a Buy from RBC Capital
UBS Analyst forecast on MEDP
Kevin Caliendo
UBS
UBS
$673
Hold
9.60%
Upside
Initiated
10/02/26
Medpace resumed with a Neutral at UBSMedpace resumed with a Neutral at UBS
Truist Financial Analyst forecast on MEDP
Jailendra Singh
Truist Financial
Truist Financial
―
Hold
―
Reiterated
09/17/26
Analysts Offer Insights on Healthcare Companies: Alkermes (NASDAQ: ALKS), Twist Bioscience (NASDAQ: TWST) and Medpace Holdings (NASDAQ: MEDP)
Jefferies Analyst forecast on MEDP
David Windley
Jefferies
Jefferies
$515→$560
Hold
-8.80%
Downside
Reiterated
09/14/26
Jefferies Sticks to Their Hold Rating for Medpace Holdings (MEDP)
BMO Capital Analyst forecast on MEDP
Sean Dodge
BMO Capital
BMO Capital
$600
Hold
-2.29%
Downside
Reiterated
07/27/26
Wall Street Analysts Are Neutral on Top Healthcare Picks
Robert W. Baird Analyst forecast on MEDP
Eric Coldwell
Robert W. Baird
Robert W. Baird
$547→$624
Hold
1.62%
Upside
Reiterated
07/24/26
Medpace price target raised to $624 from $547 at BairdMedpace price target raised to $624 from $547 at Baird
William Blair Analyst forecast on MEDP
Jared Haase
William Blair
William Blair
―
Hold
―
Reiterated
07/23/26
Medpace Rally and Record Bookings Prompt Valuation Caution as Haase Reiterates Hold Rating
Leerink Partners Analyst forecast on MEDP
Michael Cherny
Leerink Partners
Leerink Partners
$515→$620
Hold
0.97%
Upside
Reiterated
07/23/26
Medpace price target raised to $620 from $515 at LeerinkMedpace price target raised to $620 from $515 at Leerink
TD Cowen Analyst forecast on MEDP
Charles Rhyee
TD Cowen
TD Cowen
$419→$492
Hold
-19.88%
Downside
Assigned
07/23/26
Charles Rhyee Maintains Hold Rating, Raises Price Target to $492 Amid Near-Term Strength and 2027 Metabolic Concentration Risks
Deutsche Bank Analyst forecast on MEDP
Justin Bowers
Deutsche Bank
Deutsche Bank
$480→$535
Hold
-12.87%
Downside
Reiterated
07/23/26
Medpace price target raised to $535 from $480 at Deutsche BankMedpace price target raised to $535 from $480 at Deutsche Bank
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Barclays Analyst forecast on MEDP
Luke Sergott
Barclays
Barclays
$450→$625
Hold
1.78%
Upside
Reiterated
10/07/26
Medpace Holdings (MEDP) Gets a Hold from Barclays
Mizuho Securities Analyst forecast on MEDP
Ann Hynes
Mizuho Securities
Mizuho Securities
$665→$700
Buy
14.00%
Upside
Reiterated
10/07/26
Medpace price target raised to $700 from $665 at MizuhoMedpace price target raised to $700 from $665 at Mizuho
RBC Capital Analyst forecast on MEDP
Ryan Halsted
RBC Capital
RBC Capital
$692
Buy
12.69%
Upside
Reiterated
10/06/26
Medpace Holdings (MEDP) Receives a Buy from RBC Capital
UBS Analyst forecast on MEDP
Kevin Caliendo
UBS
UBS
$673
Hold
9.60%
Upside
Initiated
10/02/26
Medpace resumed with a Neutral at UBSMedpace resumed with a Neutral at UBS
Truist Financial Analyst forecast on MEDP
Jailendra Singh
Truist Financial
Truist Financial
―
Hold
―
Reiterated
09/17/26
Analysts Offer Insights on Healthcare Companies: Alkermes (NASDAQ: ALKS), Twist Bioscience (NASDAQ: TWST) and Medpace Holdings (NASDAQ: MEDP)
Jefferies Analyst forecast on MEDP
David Windley
Jefferies
Jefferies
$515→$560
Hold
-8.80%
Downside
Reiterated
09/14/26
Jefferies Sticks to Their Hold Rating for Medpace Holdings (MEDP)
BMO Capital Analyst forecast on MEDP
Sean Dodge
BMO Capital
BMO Capital
$600
Hold
-2.29%
Downside
Reiterated
07/27/26
Wall Street Analysts Are Neutral on Top Healthcare Picks
Robert W. Baird Analyst forecast on MEDP
Eric Coldwell
Robert W. Baird
Robert W. Baird
$547→$624
Hold
1.62%
Upside
Reiterated
07/24/26
Medpace price target raised to $624 from $547 at BairdMedpace price target raised to $624 from $547 at Baird
William Blair Analyst forecast on MEDP
Jared Haase
William Blair
William Blair
―
Hold
―
Reiterated
07/23/26
Medpace Rally and Record Bookings Prompt Valuation Caution as Haase Reiterates Hold Rating
Leerink Partners Analyst forecast on MEDP
Michael Cherny
Leerink Partners
Leerink Partners
$515→$620
Hold
0.97%
Upside
Reiterated
07/23/26
Medpace price target raised to $620 from $515 at LeerinkMedpace price target raised to $620 from $515 at Leerink
TD Cowen Analyst forecast on MEDP
Charles Rhyee
TD Cowen
TD Cowen
$419→$492
Hold
-19.88%
Downside
Assigned
07/23/26
Charles Rhyee Maintains Hold Rating, Raises Price Target to $492 Amid Near-Term Strength and 2027 Metabolic Concentration Risks
Deutsche Bank Analyst forecast on MEDP
Justin Bowers
Deutsche Bank
Deutsche Bank
$480→$535
Hold
-12.87%
Downside
Reiterated
07/23/26
Medpace price target raised to $535 from $480 at Deutsche BankMedpace price target raised to $535 from $480 at Deutsche Bank
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ONCBeOne Medicines
OVIDOvid Therapeutics
ASNDAscendis Pharma
QNCXQuince Therapeutics
EHCEncompass Health
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Medpace Holdings

3 Months
Ryan HalstedRBC Capital
Success Rate
2/4 ratings generated profit
50%
Average Return
+3.20%
Copying Ryan Halsted's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +3.20% per trade.
1 Year
Ann HynesMizuho Securities
Success Rate
10/11 ratings generated profit
91%
Average Return
+27.60%
Copying Ann Hynes's trades and holding each position for 1 Year would result in 90.91% of your transactions generating a profit, with an average return of +27.60% per trade.
2 Years
Ann HynesMizuho Securities
Success Rate
11/11 ratings generated profit
100%
Average Return
+42.86%
Copying Ann Hynes's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +42.86% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MEDP Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
0
0
0
0
0
Buy
5
6
6
5
2
Hold
6
12
12
14
4
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
11
18
18
19
6
In the current month, MEDP has received 2 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. MEDP average Analyst price target in the past 3 months is 612.10.
Each month's total comprises the sum of three months' worth of ratings.

MEDP Financial Forecast

MEDP Earnings Forecast

Next quarter’s earnings estimate for MEDP is $4.44 with a range of $4.31 to $4.64. The previous quarter’s EPS was $4.25. MEDP beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year MEDP has Performed in-line its overall industry.
Next quarter’s earnings estimate for MEDP is $4.44 with a range of $4.31 to $4.64. The previous quarter’s EPS was $4.25. MEDP beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year MEDP has Performed in-line its overall industry.

MEDP Sales Forecast

Next quarter’s sales forecast for MEDP is $714.47M with a range of $706.10M to $736.29M. The previous quarter’s sales results were $707.33M. MEDP beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year MEDP has Performed in-line its overall industry.
Next quarter’s sales forecast for MEDP is $714.47M with a range of $706.10M to $736.29M. The previous quarter’s sales results were $707.33M. MEDP beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year MEDP has Performed in-line its overall industry.

MEDP Stock Forecast FAQ

What is MEDP’s average 12-month price target, according to analysts?
Based on analyst ratings, Medpace Holdings’s 12-month average price target is 612.10.
    What is MEDP’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for MEDP, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is MEDP a Buy, Sell or Hold?
        Medpace Holdings has a consensus rating of Hold which is based on 2 buy ratings, 10 hold ratings and 0 sell ratings.
          What is Medpace Holdings’s price target?
          The average price target for Medpace Holdings is 612.10. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst price target is $700.00 ,the lowest forecast is $492.00. The average price target represents -0.32% Decrease from the current price of $614.06.
            What do analysts say about Medpace Holdings?
            Medpace Holdings’s analyst rating consensus is a Hold. This is based on the ratings of 12 Wall Streets Analysts.
              How can I buy shares of MEDP?
              Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.